Objective: To evaluate the presence of HIV-specific IgA antibodies as a diagnostic marker for vertical HIV infection in babies.
Study Design: A modified IgA antibody-capture enzyme-linked immunoabsorbent assay was used to detect HIV-specific IgA antibodies in serial plasma samples collected from 65 infants born to HIV infected mothers.
Results: HIV-specific IgA antibodies were detected in 80 out of 85 plasma specimens (94%) from 21 HIV infected babies. All the 71 specimens collected during the first 3 months from 44 HIV negative infants were also HIV-IgA positive (100%). Starting from four months of age, the number of samples in the seroreverter group that tested negative for HIV-IgA increased. All samples collected from these babies after eight months of age were negative for HIV-IgA. There is a significant correlation (r=0.93; p<0.005) between decline of HIV-IgA antibodies (expressed as a OD/CO ratio) and the babies' age. The predictive value of a positive result or a negative result after 8 months of age is 100%. The specificity of this assay when evaluated for babies born to seronegative women is 100%.
Conclusion: These studies present evidence for transplacental HIV-specific IgA antibodies in babies of HIV-infected mothers. Loss of these antibodies in 100% of uninfected babies after 8 months of age and its continued presence in infected babies makes this test useful in the diagnosis of HIV infection in areas where other serological tests are not reliable.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Read, S., Li, X., Major, C. et al. TRANSPLACENTAL AND AUTOLOGOUS HIV-IgA ANTIBODIES IN BABIES BORN TO SEROPOSITIVE WOMEN. † 1080. Pediatr Res 39 (Suppl 4), 182 (1996). https://doi.org/10.1203/00006450-199604001-01102
Issue Date:
DOI: https://doi.org/10.1203/00006450-199604001-01102